About MicrofluidX
MicrofluidX is a Healthcare company based in London (United Kingdom) founded in 2018 by Antoine Espinet and Cesare Cejas. It operates as a MFX offers technology updates for the Cyto Engine product through its website. It operates on a D2C model. MicrofluidX has raised $13.14 million across 6 funding rounds from investors including Esco Lifesciences, UK Research and Innovation and Cambridge Angels. The company has 10 employees. Its chief executive is Antoine Espinet. MicrofluidX offers products and services including Cyto Engine. Its focus areas include Technology, Life Sciences Tech, Digital Tools and Product Updates. Its legal entity is MICROFLUIDX LTD. Its competitors include Unibio, Univercells Tech, Nirrin Technologies, Pow.Bio and Caladan Bio and 3 more; 5 of its 8 listed competitors have raised funding.
Company details
MFX, previously MicrofluidX, is a company registered in England and Wales that focuses on providing updates for the Cyto Engine, likely a tool for cell analysis in biotech. They have rebranded and direct users to their new website for the latest information. The company engages in digital content delivery and maintains all rights reserved as of 2024, emphasizing innovation in healthcare tech.
- Headquarters London, United Kingdom
- Employees 10
- Founders Antoine Espinet, Cesare Cejas
- SectorsHealthcare
- Website microfluidx.co.uk
- Social X
- Legal Name Microfluidx Ltd
- Date of Incorporation 25 Oct, 2018
- Jurisdiction STEVENAGE, ENGLAND
- Total Equity Funding$13.14M (USD)
in 6 rounds
- Latest Funding Round$867.61K (USD), Grant
Dec 2023
- InvestorsEsco Lifesciences
& 8 more
- Employee Count10
Products & Services of MicrofluidX
MicrofluidX offers a comprehensive portfolio of products and services, including Cyto Engine.
Tool for cell analysis updates via website
Funding Insights of MicrofluidX
MicrofluidX has successfully raised a total of $13.14M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $867.61 thousand completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $13.14M
- Total Rounds 6
- Last Round Grant — $867,614
- First Round $1.72M
(Apr 2020)
- Investors Count 9
All 6 funding rounds of MicrofluidX with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2023 | $867,614 | Grant | – | – | |
| Oct 2023 | $3.05M | Seed | – | – | – |
| Dec 2022 | $4.02M | Series A | – | – | |
| Apr 2022 | $4.33M | Series A | – | – | – |
| Apr 2021 | $21,927 | Seed | – | – | – |
| Apr 2020 | $1.72M | Seed | – | UK Innovation Science & Seed Fund, Longwall Venture Partners |
9 investors in total: 9 institutional.
Investors in MicrofluidX
MicrofluidX has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Esco Lifesciences, UK Research and Innovation and Cambridge Angels.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage deeptech businesses are supported through venture capital investments. | – | longwallventures.com | Thame, United Kingdom | |
Early-stage innovations are funded by UKI2S across key sectors. | – | ukinnovationscienceseedfund.co.uk | Manchester, United Kingdom | |
Seed to growth stage investments focused venture capital and private equity firm based out of London | – | perscitusllp.com | London, United Kingdom | |
A family office based in London managing equity investments. | 2019 | puffinpoint.com | London, United Kingdom | |
Angel network investing in the UK | 2002 | cambridgeangels.com | Cambridge, United Kingdom | |
Research and innovation funding is managed for UK advancement. | 2018 | ukri.org | Swindon, United Kingdom | |
Engages in real estate development, shipping activities, and financial investments in Norway. | 2000 | jbugland.com | Norway | |
Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools | 1978 | escolifesciences.com | Singapore, Singapore | |
Provides financial advisory services including planning, analysis, and wealth management. | 2008 | 88capital.com | New York, United States |
Investor details for MicrofluidX
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of MicrofluidX
10 people are tracked at MicrofluidX (5 in leadership, 5 in team); the tracked headcount is 10.
| Name | Role | Group |
|---|---|---|
Antoine Espinet | Co-Founder, CEO | Leadership |
Cesare Cejas | Co-Founder | Leadership |
James Davies | VP of Product Development | Leadership |
James Kusena PhD | Vice President of Operations | Leadership |
Lindsey Clarke | VP Business Development & Marketing | Leadership |
Antonio De Grazia | Microfluidics Engineer | Team |
Christian A. Gutierrez | Mechatronics Engineer | Team |
Maria Kalli | Microfluidics Engineer | Team |
M G. | Microfluidics Engineer | Team |
Richard Baxter | Microfluidics Engineer | Team |
Complete people profiles for MicrofluidX
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of MicrofluidX
3 dated milestones of MicrofluidX across 5 years, from founding to its latest funding, stage changes and deals.
- Founded MicrofluidX is founded.
- Funding First funding round of $1.7M.
- Funding Latest funding round, Grant, of $868K.
Competitors of MicrofluidX
MicrofluidX has 8 listed competitors in our database, 5 of them funded. They include Unibio, Univercells Tech, Nirrin Technologies, Pow.Bio and Caladan Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unibio.dk | 2001 | Odense, Denmark | $30M | 59 | Animal feed supplements are produced using proprietary fermentation technology. | |
| univercellstech.com | 2020 | Nivelles, Belgium | – | 74 | Intensified biomanufacturing technologies for viral production are developed and manufactured. | |
| nirrin.tech | 2018 | Billerica, United States | $4.82M | 17 | Developer of sensor and integration technologies for continuous control and bioprocess automation | |
| pow.bio | 2019 | Berkeley, United States | $9.5M | – | Intelligent fermentation services for industrial and synthetic biology are provided. | |
| caladan.bio | 2023 | Brooklyn, United States | $5.11M | – | Modular bioreactors are developed for biotechnology research applications. | |
| biozeen.com | 2005 | Bengaluru, India | – | 194 | Customized bioprocess equipment and automation solutions are provided for biopharmaceuticals. | |
| dab.bio | 2012 | Delft, Netherlands | $2.23M | – | Technology solutions for accelerated fermentation of renewable feedstocks are provided. | |
| brightpathlabs.com | 2019 | Santa Fe, United States | – | – | Spinning tube-in-tube continuous-flow reactors are developed for drug manufacturing. |
Detailed competitors of MicrofluidX
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as MicrofluidX (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MicrofluidX
MicrofluidX was founded in 2018 and raised its 1st funding round 2 years after it was founded.
MicrofluidX is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Antoine Espinet is the current CEO of MicrofluidX. They have also founded this company.
MicrofluidX is a funded company, having raised a total of $13.14M across 6 funding rounds to date. The company's 1st funding round was a Seed of $1.72M, raised on Apr 2020.
MicrofluidX has 10 employees.
MFX, previously MicrofluidX, is a company registered in England and Wales that focuses on providing updates for the Cyto Engine, likely a tool for cell analysis in biotech. They have rebranded and direct users to their new website for the latest information. The company engages in digital content delivery and maintains all rights reserved as of 2024, emphasizing innovation in healthcare tech.
MicrofluidX's top competitors include Unibio, Univercells Tech and Nirrin Technologies.
MicrofluidX offers Cyto Engine.
MicrofluidX has 9 investors. Key investors include Esco Lifesciences, UK Research and Innovation, Cambridge Angels, Longwall Ventures, and UKI2S.
MicrofluidX operates through Microfluidx Ltd.